MAGNESIUM SULFATE IN WATER FOR

MAGNESIUM SULFATE IN WATER FOR was reported 12905 times

MAGNESIUM SULFATE IN WATER FOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 107 0.7643
1 VAGINAL FLATULENCE 154 0.5083
2 MITOCHONDRIAL DNA MUTATION 30 0.3488
3 NEONATAL INTESTINAL PERFORATION 12 0.3333
4 VASCULAR RESISTANCE SYSTEMIC INCREASED 10 0.1923
5 DELIVERY 108 0.1639
6 CSF OLIGOCLONAL BAND PRESENT 20 0.1538
7 HYPERMAGNESAEMIA 94 0.1440
8 NEGATIVE PRESSURE PULMONARY OEDEMA 11 0.1122
9 FEMALE GENITAL TRACT FISTULA 163 0.0954
10 AIRWAY PEAK PRESSURE INCREASED 13 0.0855
11 PCO2 INCREASED 49 0.0688
12 NEUROMUSCULAR BLOCKADE 15 0.0670
13 RADICULOPATHY 165 0.0625
14 PO2 INCREASED 30 0.0592
15 RENAL ISCHAEMIA 32 0.0585
16 TACHYCARDIA FOETAL 28 0.0561
17 PROCTITIS 154 0.0549
18 CHRONIC SINUSITIS 205 0.0546
19 PROPOFOL INFUSION SYNDROME 38 0.0539
20 ADRENAL SUPPRESSION 45 0.0534
21 BLOOD GASES ABNORMAL 28 0.0519
22 BLOOD MAGNESIUM INCREASED 46 0.0510
23 APGAR SCORE LOW 56 0.0434
24 NEUROMUSCULAR BLOCK PROLONGED 15 0.0407
25 STATUS ASTHMATICUS 19 0.0403
26 MACULAR DEGENERATION 463 0.0387
27 RESPIRATORY TRACT INFECTION BACTERIAL 19 0.0382
28 HELLP SYNDROME 23 0.0375
29 ECLAMPSIA 13 0.0354
30 PLEOCYTOSIS 20 0.0344
31 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 16 0.0329
32 DIABETES INSIPIDUS 79 0.0328
33 BLOOD PH DECREASED 56 0.0327
34 BRADYCARDIA FOETAL 27 0.0325
35 LOW BIRTH WEIGHT BABY 258 0.0324
36 NEONATAL INFECTION 11 0.0318
37 MATERNAL EXPOSURE DURING DELIVERY 31 0.0313
38 FOETAL HEART RATE DECELERATION ABNORMALITY 20 0.0283
39 POSTPARTUM HAEMORRHAGE 38 0.0282
40 PREMATURE DELIVERY 428 0.0269
41 BLOOD BICARBONATE DECREASED 50 0.0264
42 MACROGLOSSIA 14 0.0255
43 PROSTATIC PAIN 10 0.0245
44 LUNG HYPERINFLATION 21 0.0244
45 PREMATURE BABY 686 0.0228
46 PRE-ECLAMPSIA 101 0.0212
47 URETERIC STENOSIS 17 0.0212
48 C-REACTIVE PROTEIN DECREASED 13 0.0199
49 FOETAL DISTRESS SYNDROME 41 0.0193
50 KLEBSIELLA TEST POSITIVE 12 0.0184
51 NEONATAL RESPIRATORY DISTRESS SYNDROME 65 0.0184
52 SACRAL PAIN 11 0.0181
53 NEONATAL RESPIRATORY DISTRESS 17 0.0180
54 TERMINAL ILEITIS 11 0.0179
55 NEONATAL DISORDER 27 0.0170
56 FOETAL DEATH 88 0.0170
57 HYPOMAGNESAEMIA 234 0.0168
58 AMNIOTIC CAVITY INFECTION 12 0.0166
59 ENDOMETRITIS 11 0.0165
60 PO2 DECREASED 19 0.0165
61 BRONCHOPULMONARY DYSPLASIA 13 0.0161
62 SEPSIS NEONATAL 13 0.0160
63 PARAESTHESIA ORAL 229 0.0159
64 VAGINAL DISCHARGE 158 0.0156
65 NEONATAL ASPHYXIA 11 0.0155
66 GENE MUTATION 30 0.0151
67 LYMPHOCELE 10 0.0151
68 DRUG-DISEASE INTERACTION 11 0.0150
69 PERINEAL PAIN 10 0.0140
70 RESPIRATORY ACIDOSIS 55 0.0140
71 PLACENTAL DISORDER 13 0.0137
72 BLOOD MAGNESIUM DECREASED 114 0.0132
73 CEREBRAL VENTRICLE DILATATION 15 0.0130
74 ORAL CANDIDIASIS 168 0.0127
75 GINGIVAL DISORDER 49 0.0127
76 TETANY 23 0.0126
77 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 74 0.0125
78 FUNGAL SEPSIS 10 0.0120
79 OXYGEN SATURATION ABNORMAL 34 0.0120
80 DRUG EXPOSURE VIA BREAST MILK 13 0.0119
81 HYPERCAPNIA 35 0.0116
82 ABDOMINAL SEPSIS 10 0.0114
83 BLOOD UREA DECREASED 14 0.0113
84 TORSADE DE POINTES 88 0.0112
85 KLEBSIELLA SEPSIS 12 0.0106
86 CYTOKINE RELEASE SYNDROME 213 0.0106
87 ELECTROENCEPHALOGRAM ABNORMAL 33 0.0104
88 BLOOD LACTIC ACID INCREASED 55 0.0104
89 PREMATURE SEPARATION OF PLACENTA 16 0.0104
90 PNEUMONIA KLEBSIELLA 19 0.0103
91 BREECH PRESENTATION 13 0.0103
92 PREMATURE LABOUR 58 0.0102
93 HYPOTONIA NEONATAL 16 0.0102
94 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
95 VITH NERVE PARALYSIS 11 0.0096
96 PATENT DUCTUS ARTERIOSUS 38 0.0096
97 INCISION SITE PAIN 11 0.0094
98 PNEUMOPERITONEUM 17 0.0092
99 MULTI-ORGAN FAILURE 156 0.0090
100 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34 0.0089
101 FUNGAEMIA 14 0.0089
102 HYPOCALCAEMIA 166 0.0088
103 ISCHAEMIC HEPATITIS 12 0.0088
104 HYPERNATRAEMIA 43 0.0086
105 APLASTIC ANAEMIA 45 0.0086
106 RESPIRATORY TRACT INFECTION VIRAL 20 0.0086
107 FOETAL EXPOSURE DURING PREGNANCY 698 0.0086
108 MATERNAL EXPOSURE DURING PREGNANCY 762 0.0085
109 LEFT VENTRICULAR DYSFUNCTION 57 0.0085
110 CAESAREAN SECTION 99 0.0085
111 PANCREATITIS CHRONIC 20 0.0084
112 STREPTOCOCCAL SEPSIS 10 0.0084
113 PRODUCT CONTAMINATION MICROBIAL 10 0.0084
114 MYASTHENIA GRAVIS CRISIS 12 0.0081
115 NECROTISING COLITIS 10 0.0079
116 SMALL FOR DATES BABY 39 0.0078
117 ACUTE PULMONARY OEDEMA 44 0.0078
118 METHAEMOGLOBINAEMIA 18 0.0078
119 MULTIPLE-DRUG RESISTANCE 24 0.0077
120 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
121 CLONUS 21 0.0077
122 BRONCHIECTASIS 51 0.0076
123 SYSTEMIC CANDIDA 19 0.0076
124 HAEMODYNAMIC INSTABILITY 57 0.0075
125 HEPARIN-INDUCED THROMBOCYTOPENIA 36 0.0073
126 HYPOREFLEXIA 14 0.0073
127 ORAL DISORDER 53 0.0072
128 TOXIC EPIDERMAL NECROLYSIS 108 0.0071
129 PROCEDURAL PAIN 197 0.0071
130 BACTERIAL SEPSIS 23 0.0071
131 PREMATURE RUPTURE OF MEMBRANES 17 0.0070
132 EXPOSURE DURING PREGNANCY 437 0.0070
133 METABOLIC ENCEPHALOPATHY 21 0.0070
134 BLOOD CHLORIDE DECREASED 18 0.0070
135 STILLBIRTH 33 0.0068
136 ACUTE RESPIRATORY FAILURE 131 0.0068
137 LUNG CONSOLIDATION 19 0.0068
138 HYPERLACTACIDAEMIA 18 0.0067
139 LARYNGOSPASM 18 0.0067
140 HYPOALBUMINAEMIA 52 0.0067
141 BLOOD ALBUMIN DECREASED 53 0.0067
142 PRODUCT PACKAGING CONFUSION 16 0.0066
143 PNEUMONIA STAPHYLOCOCCAL 13 0.0066
144 ATELECTASIS 63 0.0065
145 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
146 HYPOPHOSPHATAEMIA 48 0.0065
147 HYPOKALAEMIA 298 0.0064
148 FOETAL GROWTH RESTRICTION 39 0.0064
149 BLOOD CALCIUM DECREASED 72 0.0064
150 COLITIS 239 0.0063
151 NEUTROPENIC SEPSIS 45 0.0063
152 FREQUENT BOWEL MOVEMENTS 170 0.0063
153 NEUTROPENIC COLITIS 13 0.0063
154 BEHAVIOUR DISORDER 34 0.0063
155 TACHYPNOEA 85 0.0062
156 VENTRICULAR TACHYCARDIA 103 0.0062
157 INTRA-UTERINE DEATH 10 0.0062
158 BACTERAEMIA 73 0.0061
159 STATUS EPILEPTICUS 69 0.0061
160 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 13 0.0061
161 FEBRILE NEUTROPENIA 399 0.0060
162 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
163 FAILURE TO THRIVE 31 0.0060
164 ENCEPHALOPATHY 145 0.0059
165 PROTEIN TOTAL DECREASED 22 0.0058
166 NEPHROGENIC ANAEMIA 27 0.0058
167 BLOOD CHLORIDE INCREASED 10 0.0058
168 ACIDOSIS 44 0.0058
169 BLOOD PHOSPHORUS DECREASED 21 0.0057
170 URINE OUTPUT DECREASED 50 0.0057
171 FEAR 153 0.0057
172 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
173 CYTOMEGALOVIRUS VIRAEMIA 25 0.0056
174 LIVE BIRTH 47 0.0056
175 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
176 ADRENAL INSUFFICIENCY 68 0.0056
177 ENTEROCOCCAL INFECTION 27 0.0056
178 BILIRUBIN CONJUGATED INCREASED 13 0.0056
179 ELECTROCARDIOGRAM QT PROLONGED 197 0.0055
180 STAPHYLOCOCCAL SEPSIS 27 0.0055
181 HYPOPROTEINAEMIA 10 0.0053
182 DERMATITIS ACNEIFORM 32 0.0053
183 DEVICE INFUSION ISSUE 13 0.0052
184 MATERNAL DRUGS AFFECTING FOETUS 40 0.0052
185 SINUS TACHYCARDIA 74 0.0052
186 VENTRICULAR EXTRASYSTOLES 54 0.0052
187 BLOOD CREATININE DECREASED 16 0.0051
188 RENAL TUBULAR NECROSIS 50 0.0051
189 PNEUMONIA FUNGAL 20 0.0051
190 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
191 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
192 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
193 VENTRICULAR FIBRILLATION 55 0.0049
194 VENTRICULAR ARRHYTHMIA 18 0.0049
195 GRAFT VERSUS HOST DISEASE 35 0.0049
196 HYPERURICAEMIA 20 0.0049
197 RECTAL HAEMORRHAGE 208 0.0048
198 TACHYARRHYTHMIA 12 0.0048
199 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
200 ANORGASMIA 13 0.0048
201 NORMAL NEWBORN 26 0.0048
202 RESPIRATORY RATE DECREASED 15 0.0048
203 INTESTINAL ISCHAEMIA 26 0.0047
204 ACUTE RESPIRATORY DISTRESS SYNDROME 83 0.0047
205 PULMONARY OEDEMA 210 0.0047
206 ENTEROCOLITIS 27 0.0047
207 BLOOD CULTURE POSITIVE 14 0.0047
208 CEREBROVASCULAR DISORDER 14 0.0046
209 DISSEMINATED INTRAVASCULAR COAGULATION 65 0.0046
210 STAPHYLOCOCCAL BACTERAEMIA 20 0.0046
211 DRUG EXPOSURE DURING PREGNANCY 156 0.0046
212 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
213 ANHEDONIA 119 0.0045
214 ESCHERICHIA SEPSIS 13 0.0045
215 RENAL INJURY 133 0.0045
216 ELECTROLYTE IMBALANCE 52 0.0045
217 RESPIRATORY DISTRESS 123 0.0045
218 HYPERBILIRUBINAEMIA 46 0.0044
219 STEM CELL TRANSPLANT 11 0.0044
220 HYPERPARATHYROIDISM SECONDARY 11 0.0044
221 HYPOXIA 154 0.0044
222 ACUTE GRAFT VERSUS HOST DISEASE 20 0.0044
223 ENCEPHALITIS 30 0.0043
224 SEPTIC SHOCK 188 0.0043
225 RESPIRATORY FAILURE 315 0.0043
226 LUNG INFILTRATION 38 0.0043
227 HYPERKALAEMIA 149 0.0042
228 BUNDLE BRANCH BLOCK LEFT 18 0.0042
229 SINUS BRADYCARDIA 41 0.0042
230 APNOEA 33 0.0042
231 PNEUMATOSIS INTESTINALIS 12 0.0042
232 PULSE ABSENT 20 0.0042
233 PARTIAL SEIZURES 22 0.0042
234 OLIGURIA 26 0.0042
235 VASCULAR DEVICE INFECTION 19 0.0042
236 INFUSION RELATED REACTION 276 0.0042
237 CLOSTRIDIAL INFECTION 14 0.0041
238 FLUID OVERLOAD 60 0.0041
239 AREFLEXIA 11 0.0041
240 BLOOD UREA INCREASED 69 0.0041
241 STRIDOR 12 0.0041
242 ILEUS PARALYTIC 18 0.0040
243 AORTIC STENOSIS 14 0.0040
244 VARICES OESOPHAGEAL 12 0.0040
245 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
246 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 20 0.0039
247 DIASTOLIC DYSFUNCTION 12 0.0039
248 CLOSTRIDIUM DIFFICILE COLITIS 41 0.0039
249 RIGHT VENTRICULAR FAILURE 27 0.0038
250 OESOPHAGITIS 42 0.0038
251 BLOOD CREATINE INCREASED 17 0.0038
252 RESPIRATORY RATE INCREASED 34 0.0038
253 ATRIAL SEPTAL DEFECT 32 0.0038
254 METABOLIC ACIDOSIS 122 0.0038
255 FLUID INTAKE REDUCED 19 0.0038
256 GESTATIONAL DIABETES 18 0.0038
257 GASTROINTESTINAL NECROSIS 11 0.0038
258 NYSTAGMUS 20 0.0038
259 RENAL FAILURE ACUTE 159 0.0037
260 HYDRONEPHROSIS 28 0.0037
261 PROCTALGIA 24 0.0037
262 COLITIS ULCERATIVE 166 0.0037
263 LUMBAR VERTEBRAL FRACTURE 17 0.0037
264 THROMBOPHLEBITIS 13 0.0037
265 PULMONARY HAEMORRHAGE 29 0.0037
266 SEPSIS 413 0.0037
267 SHOCK 85 0.0037
268 HYPOVENTILATION 12 0.0037
269 SMALL INTESTINAL OBSTRUCTION 45 0.0037
270 TRICUSPID VALVE INCOMPETENCE 29 0.0036
271 HAEMATOCHEZIA 201 0.0036
272 TUMOUR LYSIS SYNDROME 32 0.0036
273 CARDIOGENIC SHOCK 52 0.0036
274 ILEUS 45 0.0036
275 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 257 0.0036
276 BONE LESION 13 0.0036
277 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
278 BK VIRUS INFECTION 12 0.0036
279 DEVICE RELATED INFECTION 54 0.0035
280 PSEUDOMONAS INFECTION 30 0.0035
281 MALNUTRITION 39 0.0035
282 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
283 DECUBITUS ULCER 28 0.0034
284 PERIPHERAL ISCHAEMIA 14 0.0034
285 NEUROTOXICITY 60 0.0034
286 STUPOR 11 0.0034
287 TONGUE OEDEMA 13 0.0034
288 GENERALISED OEDEMA 42 0.0034
289 BONE EROSION 12 0.0034
290 MENTAL STATUS CHANGES 94 0.0034
291 RESPIRATORY ARREST 93 0.0034
292 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
293 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
294 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
295 VENTRICULAR SEPTAL DEFECT 19 0.0033
296 COAGULOPATHY 55 0.0033
297 RESPIRATORY DISORDER 98 0.0033
298 ATRIAL FLUTTER 26 0.0033
299 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
300 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
301 UNRESPONSIVE TO STIMULI 83 0.0032
302 NEUTROPHIL COUNT DECREASED 131 0.0032
303 BRONCHOPNEUMONIA 11 0.0032
304 BONE DENSITY ABNORMAL 12 0.0032
305 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
306 CARDIAC ARREST 264 0.0032
307 MITRAL VALVE INCOMPETENCE 36 0.0032
308 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
309 PLEURAL EFFUSION 191 0.0031
310 PNEUMONIA VIRAL 10 0.0031
311 BLOOD POTASSIUM DECREASED 94 0.0031
312 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
313 CUSHINGOID 10 0.0031
314 JAUNDICE CHOLESTATIC 11 0.0031
315 LOOSE TOOTH 10 0.0031
316 ADENOVIRUS INFECTION 9 0.0031
317 HYPERGLYCAEMIA 112 0.0031
318 RENAL FAILURE 407 0.0031
319 WOUND SECRETION 12 0.0031
320 PNEUMONIA BACTERIAL 28 0.0030
321 COVID-19 PNEUMONIA 36 0.0030
322 PANCYTOPENIA 170 0.0030
323 HYPERVOLAEMIA 15 0.0030
324 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
325 HYPERTRANSAMINASAEMIA 21 0.0030
326 MUCOSAL INFLAMMATION 79 0.0030
327 HAEMORRHAGE INTRACRANIAL 45 0.0030
328 PROTEIN URINE PRESENT 15 0.0030
329 CARDIOMEGALY 37 0.0030
330 OLIGOHYDRAMNIOS 10 0.0030
331 ASCITES 88 0.0030
332 RENAL FAILURE CHRONIC 23 0.0030
333 RENAL IMPAIRMENT 251 0.0030
334 ANAEMIA 564 0.0030
335 ABDOMINAL ABSCESS 13 0.0029
336 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
337 CARBOHYDRATE ANTIGEN 125 INCREASED 10 0.0029
338 PULMONARY HYPERTENSION 61 0.0029
339 CYANOSIS 46 0.0029
340 LARGE INTESTINE PERFORATION 20 0.0029
341 INJURY 202 0.0029
342 NECROTISING FASCIITIS 10 0.0028
343 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
344 HYPOTENSION 568 0.0028
345 ASPIRATION 31 0.0028
346 CHOLECYSTITIS ACUTE 16 0.0028
347 THROMBOCYTOPENIA 315 0.0028
348 BLOOD BILIRUBIN INCREASED 76 0.0028
349 ASPARTATE AMINOTRANSFERASE INCREASED 149 0.0028
350 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
351 BRONCHOSPASM 40 0.0028
352 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 21 0.0028
353 LEUKOCYTOSIS 50 0.0028
354 INTESTINAL PERFORATION 31 0.0028
355 AZOTAEMIA 11 0.0028
356 HAEMATOCRIT DECREASED 54 0.0027
357 KIDNEY TRANSPLANT REJECTION 13 0.0027
358 HYPERCHOLESTEROLAEMIA 26 0.0027
359 BRAIN OEDEMA 34 0.0027
360 PERICARDIAL EFFUSION 62 0.0027
361 COLITIS ISCHAEMIC 18 0.0027
362 CARDIAC MURMUR 23 0.0027
363 ACUTE KIDNEY INJURY 406 0.0027
364 HEPATOMEGALY 26 0.0026
365 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
366 BREATH SOUNDS ABNORMAL 13 0.0026
367 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
368 TROPONIN INCREASED 20 0.0026
369 GRAND MAL CONVULSION 24 0.0026
370 LACTIC ACIDOSIS 84 0.0026
371 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
372 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73 0.0026
373 GASTRITIS EROSIVE 12 0.0026
374 RHINOVIRUS INFECTION 10 0.0026
375 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
376 TACHYCARDIA 227 0.0026
377 DYSPEPSIA 251 0.0025
378 VENOUS THROMBOSIS 10 0.0025
379 LYMPHOCYTE COUNT DECREASED 45 0.0025
380 EMBOLISM 21 0.0025
381 BLOOD CREATININE INCREASED 165 0.0025
382 PROTEINURIA 48 0.0025
383 HYPOTONIA 25 0.0025
384 ENTERITIS 16 0.0025
385 ALANINE AMINOTRANSFERASE INCREASED 153 0.0025
386 WHEELCHAIR USER 11 0.0025
387 SERUM FERRITIN INCREASED 13 0.0025
388 PNEUMONIA ASPIRATION 61 0.0024
389 HYPONATRAEMIA 137 0.0024
390 PNEUMONITIS 66 0.0024
391 CYTOMEGALOVIRUS INFECTION 40 0.0024
392 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
393 UROSEPSIS 22 0.0024
394 LOCALISED OEDEMA 11 0.0024
395 OSTEOPENIA 36 0.0024
396 MULTIPLE MYELOMA 11 0.0024
397 CARDIOTOXICITY 21 0.0024
398 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
399 SKIN LESION 64 0.0023
400 UNEVALUABLE EVENT 175 0.0023
401 PYREXIA 799 0.0023
402 HERPES SIMPLEX 15 0.0023
403 DRUG LEVEL INCREASED 38 0.0023
404 TRANSFUSION 24 0.0023
405 DUODENAL ULCER PERFORATION 17 0.0023
406 WOUND INFECTION 25 0.0023
407 GROIN PAIN 20 0.0023
408 HYPERCALCAEMIA 28 0.0023
409 CHOLECYSTITIS 27 0.0023
410 CARDIAC FAILURE ACUTE 15 0.0022
411 NEUTROPHIL COUNT INCREASED 23 0.0022
412 PRODUCT LABEL CONFUSION 13 0.0022
413 PLATELET COUNT DECREASED 237 0.0022
414 HYPOVOLAEMIA 13 0.0022
415 ABDOMINAL TENDERNESS 11 0.0022
416 STAPHYLOCOCCAL INFECTION 73 0.0022
417 SHOCK HAEMORRHAGIC 18 0.0022
418 ATRIAL FIBRILLATION 215 0.0022
419 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
420 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
421 HYPERLIPIDAEMIA 26 0.0022
422 OXYGEN SATURATION DECREASED 121 0.0022
423 ENDOCARDITIS 11 0.0021
424 NEPHROPATHY TOXIC 24 0.0021
425 HYPOGAMMAGLOBULINAEMIA 14 0.0021
426 RESPIRATORY DEPRESSION 26 0.0021
427 BRADYCARDIA 112 0.0021
428 BRAIN INJURY 21 0.0021
429 STRESS CARDIOMYOPATHY 12 0.0021
430 HEPATIC FAILURE 62 0.0021
431 THROMBOTIC MICROANGIOPATHY 20 0.0021
432 HYPOPHAGIA 52 0.0020
433 END STAGE RENAL DISEASE 37 0.0020
434 FLANK PAIN 19 0.0020
435 ABDOMINAL PAIN 471 0.0020
436 HYDROCEPHALUS 11 0.0020
437 PROTHROMBIN TIME PROLONGED 12 0.0020
438 EXTRASYSTOLES 14 0.0020
439 MIOSIS 16 0.0020
440 DELIRIUM 69 0.0020
441 GASTROENTERITIS 29 0.0020
442 DUODENAL ULCER 14 0.0020
443 MYASTHENIA GRAVIS 16 0.0020
444 NO THERAPEUTIC RESPONSE 24 0.0020
445 HYPERTHERMIA 15 0.0020
446 APHASIA 59 0.0020
447 DEHYDRATION 260 0.0019
448 PERONEAL NERVE PALSY 11 0.0019
449 SPINAL COMPRESSION FRACTURE 16 0.0019
450 LUNG INFECTION 30 0.0019
451 HIATUS HERNIA 25 0.0019
452 MALABSORPTION 10 0.0019
453 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 105 0.0019
454 BODY TEMPERATURE INCREASED 39 0.0019
455 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
456 HYPERTRIGLYCERIDAEMIA 11 0.0019
457 BACTERIAL INFECTION 35 0.0019
458 TRANSPLANT REJECTION 15 0.0019
459 BLOOD DISORDER 15 0.0019
460 C-REACTIVE PROTEIN INCREASED 68 0.0019
461 COMPRESSION FRACTURE 10 0.0019
462 EJECTION FRACTION DECREASED 29 0.0019
463 NEUTROPENIA 253 0.0019
464 ANAL ABSCESS 10 0.0019
465 PYELONEPHRITIS 16 0.0018
466 RASH MACULO-PAPULAR 41 0.0018
467 IRON DEFICIENCY ANAEMIA 17 0.0018
468 DRUG TOXICITY 25 0.0018
469 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
470 ESCHERICHIA INFECTION 15 0.0018
471 WHEEZING 108 0.0018
472 PULMONARY CONGESTION 24 0.0018
473 CONSTIPATION 393 0.0018
474 TRANSAMINASES INCREASED 40 0.0018
475 WRONG DRUG ADMINISTERED 16 0.0018
476 ARRHYTHMIA 85 0.0018
477 ANOREXIA 23 0.0018
478 WRONG PRODUCT ADMINISTERED 12 0.0018
479 POST PROCEDURAL COMPLICATION 34 0.0018
480 STOMATITIS 107 0.0018
481 RENAL CYST 14 0.0018
482 CIRCULATORY COLLAPSE 30 0.0018
483 DEPRESSED LEVEL OF CONSCIOUSNESS 69 0.0017
484 LIP SWELLING 58 0.0017
485 OEDEMA 94 0.0017
486 BONE MARROW FAILURE 35 0.0017
487 RALES 10 0.0017
488 SKIN WARM 10 0.0017
489 ANGIOEDEMA 76 0.0017
490 PNEUMOTHORAX 27 0.0017
491 LEUKOPENIA 85 0.0017
492 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
493 LIPASE INCREASED 13 0.0017
494 HEPATIC FUNCTION ABNORMAL 63 0.0017
495 SUBDURAL HAEMATOMA 24 0.0017
496 DYSGRAPHIA 11 0.0017
497 GANGRENE 10 0.0017
498 PERITONITIS 34 0.0016
499 OEDEMA PERIPHERAL 200 0.0016
500 GASTRITIS 43 0.0016
501 POST PROCEDURAL HAEMORRHAGE 19 0.0016
502 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
503 ANURIA 14 0.0016
504 RHINITIS 13 0.0016
505 HEPATIC ENCEPHALOPATHY 15 0.0016
506 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
507 HYPOTHYROIDISM 51 0.0016
508 HYPERAESTHESIA 13 0.0016
509 HYPOTHERMIA 16 0.0016
510 BLOOD PRESSURE DECREASED 105 0.0016
511 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
512 MEDICATION ERROR 87 0.0016
513 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
514 MYOSITIS 14 0.0016
515 PULMONARY TOXICITY 11 0.0016
516 ATRIOVENTRICULAR BLOCK 12 0.0016
517 CONGENITAL ANOMALY 12 0.0015
518 HAEMOGLOBIN DECREASED 159 0.0015
519 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
520 MELAENA 34 0.0015
521 PATHOGEN RESISTANCE 14 0.0015
522 RESPIRATORY TRACT INFECTION 40 0.0015
523 ASPERGILLUS INFECTION 10 0.0015
524 PNEUMONIA 489 0.0015
525 DEEP VEIN THROMBOSIS 98 0.0015
526 PSYCHOLOGICAL TRAUMA 13 0.0015
527 HAEMOPTYSIS 42 0.0015
528 MOUTH HAEMORRHAGE 11 0.0015
529 DRUG INTERACTION 238 0.0015
530 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
531 CELLULITIS 75 0.0015
532 EMPHYSEMA 15 0.0015
533 STEVENS-JOHNSON SYNDROME 33 0.0015
534 LIVER FUNCTION TEST ABNORMAL 43 0.0015
535 EMOTIONAL DISTRESS 179 0.0015
536 ACUTE MYELOID LEUKAEMIA 23 0.0015
537 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
538 ERYTHEMA 301 0.0015
539 ANAPHYLACTIC REACTION 80 0.0014
540 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
541 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
542 PETECHIAE 15 0.0014
543 BLOOD SODIUM DECREASED 27 0.0014
544 HAEMATOMA 37 0.0014
545 INTERSTITIAL LUNG DISEASE 69 0.0014
546 JOINT DISLOCATION 15 0.0014
547 DISABILITY 28 0.0014
548 CARDIO-RESPIRATORY ARREST 59 0.0014
549 CHILLS 165 0.0014
550 DIVERTICULUM 10 0.0014
551 CEREBRAL HAEMORRHAGE 50 0.0014
552 DISEASE RECURRENCE 66 0.0014
553 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
554 HEPATIC CIRRHOSIS 26 0.0014
555 CARDIAC FAILURE 111 0.0014
556 DYSPNOEA EXERTIONAL 52 0.0014
557 WEIGHT DECREASED 384 0.0014
558 LETHARGY 79 0.0014
559 SPINAL OSTEOARTHRITIS 12 0.0014
560 CHOLESTASIS 26 0.0014
561 CARDIOMYOPATHY 20 0.0014
562 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
563 CEREBRAL INFARCTION 33 0.0013
564 HAEMATURIA 46 0.0013
565 WHITE BLOOD CELL COUNT DECREASED 145 0.0013
566 CARDIAC FAILURE CONGESTIVE 106 0.0013
567 HAEMODIALYSIS 11 0.0013
568 PANCREATITIS 69 0.0013
569 PROCEDURAL COMPLICATION 10 0.0013
570 DYSURIA 48 0.0013
571 BLOOD POTASSIUM INCREASED 21 0.0013
572 FACIAL PARALYSIS 11 0.0013
573 ACUTE MYOCARDIAL INFARCTION 38 0.0013
574 THIRST 23 0.0013
575 PALLOR 35 0.0013
576 ANXIETY 365 0.0013
577 BLOOD GLUCOSE FLUCTUATION 14 0.0013
578 NEURALGIA 31 0.0013
579 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
580 MYOPATHY 11 0.0013
581 LYMPHOPENIA 18 0.0013
582 DIALYSIS 18 0.0013
583 ORTHOSTATIC HYPOTENSION 22 0.0013
584 FURUNCLE 10 0.0013
585 HYPOGLYCAEMIA 61 0.0013
586 MUSCULAR WEAKNESS 141 0.0012
587 PRODUCT USE IN UNAPPROVED INDICATION 306 0.0012
588 MUSCULOSKELETAL CHEST PAIN 19 0.0012
589 GENERAL PHYSICAL HEALTH DETERIORATION 142 0.0012
590 DYSPHAGIA 116 0.0012
591 POLYURIA 10 0.0012
592 CHOLELITHIASIS 40 0.0012
593 DEVELOPMENTAL DELAY 11 0.0012
594 HICCUPS 10 0.0012
595 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
596 PULMONARY EMBOLISM 115 0.0012
597 MUSCLE INJURY 10 0.0012
598 SLEEP APNOEA SYNDROME 23 0.0012
599 SPLENOMEGALY 14 0.0012
600 ECONOMIC PROBLEM 18 0.0012
601 DRUG ERUPTION 21 0.0012
602 ERYTHEMA MULTIFORME 11 0.0012
603 SUBARACHNOID HAEMORRHAGE 12 0.0012
604 NEUROPATHY PERIPHERAL 112 0.0012
605 CONFUSIONAL STATE 190 0.0012
606 HYPERTENSION 249 0.0012
607 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
608 GASTROINTESTINAL HAEMORRHAGE 98 0.0012
609 ARTERIOSCLEROSIS 11 0.0012
610 INTESTINAL OBSTRUCTION 44 0.0012
611 POISONING DELIBERATE 11 0.0012
612 THERAPY NON-RESPONDER 52 0.0012
613 URINARY TRACT INFECTION 197 0.0012
614 ASTHMA 130 0.0011
615 PULMONARY FIBROSIS 22 0.0011
616 ECZEMA 60 0.0011
617 PAIN 703 0.0011
618 FOLLICULITIS 12 0.0011
619 VOMITING 536 0.0011
620 URINARY RETENTION 38 0.0011
621 SKIN ULCER 29 0.0011
622 DYSARTHRIA 42 0.0011
623 DRUG DISPENSING ERROR 17 0.0011
624 CHRONIC KIDNEY DISEASE 84 0.0011
625 SKIN LACERATION 12 0.0011
626 ABDOMINAL DISTENSION 115 0.0011
627 CHEST PAIN 204 0.0011
628 BONE DISORDER 20 0.0011
629 METASTASES TO BONE 18 0.0011
630 RESTLESSNESS 40 0.0011
631 LOSS OF CONSCIOUSNESS 140 0.0011
632 DISEASE PROGRESSION 129 0.0011
633 CORONARY ARTERY DISEASE 33 0.0011
634 EOSINOPHILIA 19 0.0011
635 DIABETIC KETOACIDOSIS 26 0.0011
636 TOOTH ABSCESS 11 0.0011
637 NAUSEA 852 0.0011
638 HEPATIC STEATOSIS 20 0.0011
639 IMMUNODEFICIENCY 16 0.0011
640 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
641 APPENDICITIS 10 0.0011
642 CYSTITIS 34 0.0011
643 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
644 CONVULSION 61 0.0011
645 CANDIDA INFECTION 18 0.0011
646 DYSPNOEA 603 0.0011
647 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
648 SYNCOPE 106 0.0011
649 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
650 WEIGHT FLUCTUATION 11 0.0011
651 MALAISE 461 0.0011
652 SKIN IRRITATION 48 0.0010
653 DIVERTICULITIS 29 0.0010
654 AUTOIMMUNE DISORDER 10 0.0010
655 ACUTE HEPATIC FAILURE 14 0.0010
656 UPPER RESPIRATORY TRACT INFECTION 47 0.0010
657 EPISTAXIS 76 0.0010
658 BODY TEMPERATURE DECREASED 10 0.0010
659 RED BLOOD CELL COUNT DECREASED 29 0.0010
660 FEELING HOT 62 0.0010
661 INFUSION SITE PAIN 13 0.0010
662 RHABDOMYOLYSIS 42 0.0010
663 MYOCLONUS 12 0.0010
664 FEELING COLD 28 0.0010
665 BACK PAIN 233 0.0010
666 ABSCESS 16 0.0010
667 GASTRIC ULCER 19 0.0010
668 DIARRHOEA 645 0.0010
669 PLATELET COUNT INCREASED 13 0.0010
670 MOUTH ULCERATION 21 0.0010
671 FOOT DEFORMITY 11 0.0010
672 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
673 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
674 HAEMORRHOIDS 19 0.0010
675 LIVER DISORDER 43 0.0010
676 VAGINAL HAEMORRHAGE 42 0.0010
677 MALIGNANT NEOPLASM PROGRESSION 99 0.0010
678 MYOCARDIAL ISCHAEMIA 11 0.0010
679 JAUNDICE 26 0.0010
680 DECREASED APPETITE 224 0.0010
681 HYPOKINESIA 14 0.0010
682 OFF LABEL USE 839 0.0010
683 BLOOD PRESSURE ABNORMAL 19 0.0010
684 DERMATITIS ALLERGIC 12 0.0010
685 CHEST DISCOMFORT 97 0.0009
686 MUSCLE ATROPHY 12 0.0009
687 INCONTINENCE 10 0.0009
688 ASTHENIA 355 0.0009
689 OBESITY 15 0.0009
690 OSTEOMYELITIS 17 0.0009
691 MYDRIASIS 12 0.0009
692 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
693 FLUSHING 94 0.0009
694 RIB FRACTURE 19 0.0009
695 OSTEOARTHRITIS 39 0.0009
696 SEIZURE 106 0.0009
697 AGRANULOCYTOSIS 17 0.0009
698 SKIN DISCOLOURATION 42 0.0009
699 DRUG INEFFECTIVE 1204 0.0009
700 COLD SWEAT 16 0.0009
701 GASTROOESOPHAGEAL REFLUX DISEASE 73 0.0009
702 DENTAL CARIES 10 0.0009
703 RASH ERYTHEMATOUS 43 0.0009
704 HYPERTENSIVE CRISIS 10 0.0009
705 DRUG RESISTANCE 23 0.0009
706 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
707 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
708 ORAL PAIN 20 0.0009
709 ANAPHYLACTIC SHOCK 23 0.0009
710 FISTULA 10 0.0009
711 CHROMATURIA 20 0.0009
712 LIVER FUNCTION TEST INCREASED 19 0.0009
713 POOR QUALITY SLEEP 19 0.0009
714 CONDITION AGGRAVATED 268 0.0009
715 ULCER 14 0.0009
716 SEDATION 23 0.0009
717 NECK PAIN 49 0.0009
718 OSTEOPOROSIS 36 0.0009
719 BLOOD PRESSURE FLUCTUATION 21 0.0009
720 PULMONARY MASS 13 0.0009
721 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
722 METASTASES TO LUNG 10 0.0009
723 TOXICITY TO VARIOUS AGENTS 144 0.0009
724 METASTASES TO LIVER 15 0.0009
725 INFECTION 123 0.0008
726 BLOOD IRON DECREASED 10 0.0008
727 ISCHAEMIC STROKE 15 0.0008
728 COMA 40 0.0008
729 MUSCULOSKELETAL PAIN 44 0.0008
730 RENAL DISORDER 39 0.0008
731 PERICARDITIS 14 0.0008
732 SEROTONIN SYNDROME 16 0.0008
733 TREMOR 138 0.0008
734 AGITATION 61 0.0008
735 MYELODYSPLASTIC SYNDROME 12 0.0008
736 SOMNOLENCE 167 0.0008
737 HEART RATE INCREASED 82 0.0008
738 HEMIPARESIS 14 0.0008
739 HEART RATE DECREASED 29 0.0008
740 MUSCLE TWITCHING 19 0.0008
741 PRESYNCOPE 20 0.0008
742 DEPRESSION 187 0.0008
743 DYSPHONIA 48 0.0008
744 LIVER INJURY 20 0.0008
745 PAIN IN JAW 23 0.0008
746 SKIN DISORDER 27 0.0008
747 CEREBROVASCULAR ACCIDENT 137 0.0008
748 DISORIENTATION 32 0.0008
749 GINGIVAL BLEEDING 11 0.0008
750 TOOTH EXTRACTION 10 0.0008
751 PALPITATIONS 94 0.0008
752 BLISTER 45 0.0008
753 PANCREATITIS ACUTE 18 0.0008
754 AMNESIA 52 0.0008
755 ABDOMINAL PAIN LOWER 20 0.0008
756 COORDINATION ABNORMAL 11 0.0008
757 PRODUCT PREPARATION ERROR 16 0.0008
758 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
759 RASH GENERALISED 20 0.0008
760 TYPE 2 DIABETES MELLITUS 26 0.0008
761 PARALYSIS 11 0.0008
762 BLOOD PRESSURE INCREASED 117 0.0008
763 DRUG-INDUCED LIVER INJURY 24 0.0008
764 DYSSTASIA 22 0.0008
765 HAEMATEMESIS 19 0.0007
766 PREGNANCY 15 0.0007
767 CARDIOVASCULAR DISORDER 19 0.0007
768 BURNING SENSATION 52 0.0007
769 FOOT FRACTURE 14 0.0007
770 COLON CANCER 11 0.0007
771 FAECES DISCOLOURED 16 0.0007
772 PARAESTHESIA 116 0.0007
773 IMPAIRED HEALING 24 0.0007
774 MULTIPLE FRACTURES 12 0.0007
775 LOWER LIMB FRACTURE 14 0.0007
776 SLEEP DISORDER 51 0.0007
777 GASTROENTERITIS VIRAL 13 0.0007
778 HEPATOTOXICITY 16 0.0007
779 ORAL HERPES 14 0.0007
780 GLOSSODYNIA 16 0.0007
781 HYPERHIDROSIS 92 0.0007
782 TREATMENT NONCOMPLIANCE 39 0.0007
783 MOBILITY DECREASED 51 0.0007
784 HEADACHE 444 0.0007
785 LYMPHADENOPATHY 25 0.0007
786 CONJUNCTIVITIS 13 0.0007
787 DRUG INTOLERANCE 67 0.0007
788 FALL 230 0.0007
789 HAEMORRHAGE 72 0.0007
790 HYPOAESTHESIA 103 0.0007
791 BLOOD CHOLESTEROL INCREASED 32 0.0007
792 CONTUSION 66 0.0007
793 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
794 EMOTIONAL DISORDER 21 0.0007
795 COUGH 191 0.0007
796 INCREASED APPETITE 13 0.0007
797 RASH 296 0.0007
798 EAR INFECTION 18 0.0007
799 LUNG DISORDER 33 0.0007
800 PRODUCT PRESCRIBING ERROR 16 0.0007
801 EAR PAIN 13 0.0007
802 URTICARIA 112 0.0007
803 HEPATITIS 17 0.0007
804 HEART RATE IRREGULAR 15 0.0007
805 TOOTHACHE 12 0.0007
806 ERECTILE DYSFUNCTION 17 0.0007
807 RESTLESS LEGS SYNDROME 12 0.0007
808 GAIT INABILITY 22 0.0007
809 TINNITUS 30 0.0007
810 FACE OEDEMA 11 0.0007
811 NERVOUSNESS 34 0.0007
812 JOINT STIFFNESS 17 0.0006
813 ABASIA 16 0.0006
814 HEPATIC ENZYME INCREASED 44 0.0006
815 WOUND 18 0.0006
816 PSYCHOTIC DISORDER 19 0.0006
817 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
818 URINARY INCONTINENCE 19 0.0006
819 NERVOUS SYSTEM DISORDER 20 0.0006
820 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
821 INTENTIONAL OVERDOSE 41 0.0006
822 OROPHARYNGEAL PAIN 59 0.0006
823 RHINORRHOEA 41 0.0006
824 NEOPLASM PROGRESSION 22 0.0006
825 ACCIDENTAL OVERDOSE 23 0.0006
826 PRODUCTIVE COUGH 30 0.0006
827 SCIATICA 10 0.0006
828 MUSCLE SPASMS 114 0.0006
829 DERMATITIS 13 0.0006
830 DYSGEUSIA 46 0.0006
831 LABORATORY TEST ABNORMAL 18 0.0006
832 RETCHING 13 0.0006
833 FLUID RETENTION 31 0.0006
834 RASH PRURITIC 33 0.0006
835 OSTEONECROSIS OF JAW 15 0.0006
836 PANIC ATTACK 22 0.0006
837 THROAT IRRITATION 27 0.0006
838 PRESCRIBED UNDERDOSE 12 0.0006
839 FATIGUE 468 0.0006
840 VIRAL INFECTION 20 0.0006
841 POLLAKIURIA 25 0.0006
842 MENTAL DISORDER 26 0.0006
843 BLOOD GLUCOSE ABNORMAL 11 0.0006
844 DIZZINESS 296 0.0006
845 COVID-19 104 0.0006
846 ILL-DEFINED DISORDER 36 0.0006
847 PHOTOPHOBIA 11 0.0006
848 THROMBOSIS 47 0.0006
849 SCAR 10 0.0006
850 ABDOMINAL PAIN UPPER 120 0.0006
851 FLATULENCE 33 0.0006
852 MUSCULOSKELETAL DISCOMFORT 10 0.0006
853 BLOOD URINE PRESENT 11 0.0006
854 FUNGAL INFECTION 19 0.0006
855 DYSKINESIA 23 0.0006
856 PLASMA CELL MYELOMA 22 0.0006
857 GOUT 10 0.0006
858 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
859 SINUS DISORDER 11 0.0006
860 PRURITUS GENERALISED 12 0.0006
861 SWELLING FACE 35 0.0005
862 THINKING ABNORMAL 10 0.0005
863 WEIGHT INCREASED 120 0.0005
864 BRONCHITIS 39 0.0005
865 NEPHROLITHIASIS 24 0.0005
866 CRYING 19 0.0005
867 BLOOD GLUCOSE DECREASED 25 0.0005
868 THROAT TIGHTNESS 14 0.0005
869 HALLUCINATION 39 0.0005
870 EYE DISORDER 17 0.0005
871 SPEECH DISORDER 27 0.0005
872 JOINT INJURY 11 0.0005
873 INSOMNIA 137 0.0005
874 COGNITIVE DISORDER 24 0.0005
875 VERTIGO 31 0.0005
876 ABNORMAL BEHAVIOUR 20 0.0005
877 MIGRAINE 48 0.0005
878 INTENTIONAL PRODUCT USE ISSUE 44 0.0005
879 ABDOMINAL DISCOMFORT 84 0.0005
880 DIPLOPIA 13 0.0005
881 GAIT DISTURBANCE 95 0.0005
882 MENTAL IMPAIRMENT 12 0.0005
883 FIBROMYALGIA 12 0.0005
884 FEEDING DISORDER 10 0.0005
885 PAIN IN EXTREMITY 145 0.0005
886 DISCOMFORT 30 0.0005
887 CARDIAC DISORDER 46 0.0005
888 HYPOACUSIS 21 0.0005
889 HERPES ZOSTER 28 0.0005
890 INFLUENZA LIKE ILLNESS 40 0.0005
891 TOOTH LOSS 10 0.0005
892 MYALGIA 82 0.0005
893 MEMORY IMPAIRMENT 66 0.0005
894 DIABETES MELLITUS 36 0.0005
895 TREATMENT FAILURE 39 0.0005
896 PRODUCT SUBSTITUTION ISSUE 27 0.0005
897 IRRITABLE BOWEL SYNDROME 10 0.0005
898 SWELLING 43 0.0005
899 RASH MACULAR 16 0.0005
900 LOCALISED INFECTION 11 0.0005
901 DEATH 391 0.0005
902 ANGINA PECTORIS 13 0.0005
903 HYPERSOMNIA 13 0.0005
904 MYOCARDIAL INFARCTION 79 0.0005
905 VISION BLURRED 62 0.0005
906 BLOOD GLUCOSE INCREASED 85 0.0005
907 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
908 DISTURBANCE IN ATTENTION 24 0.0004
909 VISUAL IMPAIRMENT 54 0.0004
910 NIGHT SWEATS 14 0.0004
911 ARTHRITIS 34 0.0004
912 LACRIMATION INCREASED 13 0.0004
913 EYE SWELLING 16 0.0004
914 DEMENTIA 12 0.0004
915 BONE PAIN 25 0.0004
916 PRURITUS 164 0.0004
917 OSTEONECROSIS 14 0.0004
918 EPILEPSY 13 0.0004
919 HOT FLUSH 32 0.0004
920 OVERDOSE 91 0.0004
921 INFLUENZA 47 0.0004
922 AGGRESSION 21 0.0004
923 MUSCULOSKELETAL STIFFNESS 36 0.0004
924 HEAD INJURY 13 0.0004
925 PAIN OF SKIN 11 0.0004
926 HIP FRACTURE 13 0.0004
927 PERIPHERAL SWELLING 62 0.0004
928 ALOPECIA 79 0.0004
929 DRY EYE 20 0.0004
930 SINUSITIS 41 0.0004
931 ARTHRALGIA 163 0.0004
932 DRUG ADMINISTRATION ERROR 12 0.0004
933 MYELOSUPPRESSION 14 0.0004
934 LIMB DISCOMFORT 12 0.0004
935 FEMUR FRACTURE 12 0.0004
936 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
937 DEAFNESS 10 0.0004
938 SKIN EXFOLIATION 32 0.0004
939 JOINT SWELLING 45 0.0004
940 BALANCE DISORDER 32 0.0004
941 PSORIATIC ARTHROPATHY 15 0.0004
942 ROAD TRAFFIC ACCIDENT 15 0.0004
943 NASOPHARYNGITIS 66 0.0004
944 NASAL CONGESTION 21 0.0004
945 CATARACT 21 0.0004
946 ILLNESS 36 0.0003
947 INFLAMMATION 18 0.0003
948 GASTROINTESTINAL DISORDER 31 0.0003
949 MOVEMENT DISORDER 11 0.0003
950 HYPERSENSITIVITY 62 0.0003
951 DRY MOUTH 27 0.0003
952 IRRITABILITY 20 0.0003
953 THERAPEUTIC RESPONSE DECREASED 20 0.0003
954 FEELING ABNORMAL 79 0.0003
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
956 HOSPITALISATION 50 0.0003
957 SWOLLEN TONGUE 10 0.0003
958 INCORRECT DOSE ADMINISTERED 73 0.0003
959 NEOPLASM MALIGNANT 21 0.0003
960 PRODUCT USE ISSUE 59 0.0003
961 SURGERY 18 0.0003
962 ARTHROPATHY 17 0.0003
963 DEPRESSED MOOD 16 0.0003
964 EYE PAIN 17 0.0003
965 MULTIPLE SCLEROSIS 14 0.0003
966 GASTRIC DISORDER 10 0.0003
967 SUICIDE ATTEMPT 17 0.0003
968 OCULAR HYPERAEMIA 13 0.0003
969 RHEUMATOID ARTHRITIS 31 0.0003
970 BLINDNESS 11 0.0003
971 ADVERSE EVENT 24 0.0003
972 LUNG NEOPLASM MALIGNANT 10 0.0002
973 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
974 DRY SKIN 29 0.0002
975 INTENTIONAL PRODUCT MISUSE 19 0.0002
976 DRUG WITHDRAWAL SYNDROME 19 0.0002
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
978 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
980 DRUG ABUSE 16 0.0002
981 ADVERSE DRUG REACTION 17 0.0002
982 DEVICE MALFUNCTION 13 0.0002
983 PSORIASIS 24 0.0002
984 NO ADVERSE EVENT 32 0.0002
985 PRODUCT DOSE OMISSION ISSUE 48 0.0002
986 INJECTION SITE ERYTHEMA 20 0.0002
987 DRUG DOSE OMISSION 23 0.0001
988 ACNE 10 0.0001
989 SUICIDAL IDEATION 12 0.0001
990 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
991 COMPLETED SUICIDE 10 0.0001
992 PRODUCT QUALITY ISSUE 14 0.0001
993 INJECTION SITE PAIN 28 0.0001
994 DRUG DEPENDENCE 13 0.0001